HIV Viral Load Testing in the South African Public Health Setting in the Context of Evolving ART Guidelines and Advances in Technology, 2013–2022
暂无分享,去创建一个
D. Hardie | P. D. da Silva | N. Cassim | L. Hans | W. Stevens | Somayya Sarang | Silence Ndlovu | W. D. F. Venter
[1] M. Siedner,et al. Adherence, resistance, and viral suppression on dolutegravir in sub-Saharan Africa: implications for the TLD era , 2021, AIDS.
[2] S. Rosen,et al. Reduction in initiations of HIV treatment in South Africa during the COVID pandemic , 2021, BMC Health Services Research.
[3] N. Ford,et al. Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis , 2020, EClinicalMedicine.
[4] J. Hodson,et al. Correlation between Cepheid GeneXpert and Abbott M2000 assays for HIV viral load measurements , 2020, International journal of STD & AIDS.
[5] C. Prégermain,et al. Comparison of the Abbott Alinity m and m2000 assays for the quantification of HIV-1, HCV and HBV in clinical samples. , 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[6] Robert W Eisinger,et al. HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. , 2019, JAMA.
[7] M. Fox,et al. Changing the South African national antiretroviral therapy guidelines: The role of cost modelling , 2017, PloS one.
[8] S. Lawn,et al. Rates of Switching Antiretroviral Drugs in a Primary Care Service in South Africa before and after Introduction of Tenofovir , 2013, PloS one.
[9] Bryan R Cobb,et al. Evolution in the sensitivity of quantitative HIV-1 viral load tests. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[10] Wendy S Stevens,et al. Challenges in implementing HIV load testing in South Africa. , 2010, The Journal of infectious diseases.
[11] R. Pennell,et al. HIV/AIDS , 2006 .
[12] D. Chernoff. The Significance of HIV Viral Load Assay Precision: A Review of the Package Insert Specifications of Two Commercial Kits , 2002, Journal of the International Association of Physicians in AIDS Care.
[13] R. Dewar,et al. Comparative Analysis of HIV-1 Viral Load Assays on Subtype Quantification: Bayer Versant HIV-1 RNA 3.0 Versus Roche Amplicor HIV-1 Monitor Version 1.5 , 2002 .
[14] H Jacqmin-Gadda,et al. Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment , 2000, AIDS.
[15] Roger Detels,et al. Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.
[16] F. Brun-Vézinet,et al. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma , 1996, Journal of clinical microbiology.
[17] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[18] Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV , 2020 .
[19] James Curran,et al. Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach , 2005 .
[20] N. Michael,et al. Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.
[21] J. E. Kerrich. Statistics in South Africa , 1968 .